[ET Net News Agency, 15 July 2025]  CSPC PHARMA (01093) rose 5.9% to HK$8.46. 
  It hits an intra-day high of HK$8.46, and an intra-day low of HK$7.95. The total shares 
traded was 115.09 million, with a value of HK$939.63m. The active buy/sell ratio is 64:36,
with net buying turnover of HK$252.22m. CLSA LTD accounts for greatest net responsive 
buying turnover of HK$11.85m, with volume weighted average price of HK$8.15. CITIGROUP  
GLOBAL accounts for greatest net responsive selling turnover of HK$30.27m, with volume  
weighted average price of HK$8.151. The stock has risen a combined 6.5% over the past 2 
consecutive trading days. 
  The Hang Seng Index now rose 66 points, or 0.3% to 24,270; the Hang Seng China  
Enterprises Index now rose 17 points, or 0.2% to 8,749. 
  
           Basic Information
           =================
  
  ----------------------------------- 
  Nominal     8.460 % Chg     +5.88%
  High        8.460 Low        7.950
  Shares Tr 115.09m Turnover 939.63m
  10-D SMA    8.061 %H.V      43.887
  20-D SMA    7.954 VWAP       8.164
  50-D SMA    7.398 RSI14     61.489
  ----------------------------------- 
Status: Active buy/sell ratio is 64:36, with net buying turnover of HK$252.22m, rising a  
combined 6.5% over the past 2 consecutive trading days
  
Performance of stocks in the same sector or of relevance
========================================================
  
  Stock (Code)            Price (HK$) Change (%)
  ----------------------------------------------- 
  CSPC PHARMA (01093)            8.46      +5.88
  SINOPHARM (01099)             18.88      -1.36
  SINO BIOPHARM (01177)          6.29      +3.62
  INNOVENT BIO (01801)          83.80      +2.20
  WUXI BIO (02269)              26.70      -0.19
  WUXI APPTEC (02359)           88.85      +0.62
  CHINARES PHARMA (03320)        5.26      -1.13
  HANSOH PHARMA (03692)         33.05      +1.38
  BEIGENE (06160)              161.00      +5.57
  AKESO (09926)                119.00      +0.68
  ----------------------------------------------- 
  (ed)



 
 